Repidose Ready Pulse Ireland - English - HPRA (Health Products Regulatory Authority)

repidose ready pulse

intervet ireland limited - oxfendazole - pulsatile-release intraruminal device - 1250 mg/tablet - oxfendazole - cattle - endoparasiticide

REPIDOSE READY PULSE Ireland - English - HPRA (Health Products Regulatory Authority)

repidose ready pulse

schering plough limited - oxfendazole - bolus - 1250 milligram - bovine - endoparasiticide

REPIDOSE READY PULSE Ireland - English - HPRA (Health Products Regulatory Authority)

repidose ready pulse

intervet ireland limited - oxfendazole - bolus - 1250 milligram - oxfendazole - bovine - endoparasiticide

REPIDOSE FIRST GRAZER Ireland - English - HPRA (Health Products Regulatory Authority)

repidose first grazer

schering plough limited - oxfendazole - tablets - bovine - endoparasiticide

REPIDOSE MID SEASON Ireland - English - HPRA (Health Products Regulatory Authority)

repidose mid season

schering ag - oxfendazole - bolus - bovine - endoparasiticide

DEXAMETHASONE injection, solution United States - English - NLM (National Library of Medicine)

dexamethasone injection, solution

vedco, inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - dexamethasone 2 mg in 1 ml - dexamethasone injection 2 mg/ml is indcated for  the treatment of primary bovine ketosis an as an anti-inflammatory agent in the bovine and equine. as supportive therapy, dexamethasone injection 2 mg/ml may be used in the management of vairious rheumatic, allergic dermatologic, and other diseases known to be responsive to anti-inflammatory corticosteroids.  dexamethasone injection 2 mg/ml may be used intravenously as supportive therapy when an immeidate hormonal response is required. bovine ketosis dexamethasone injection 2 mg/ml is offered for the treatment of primary ktosis.  the gluconeogenic effects of dexamethasone injection 2 mg/ml, when administered intramuscularyly, are generally noted within the first 5 to 12 hours.  when dexamethasone injection 2 mg/ml is used intravenously, the effects may be noted sooner.  blood sugar levels rise to normal levels repidly and genreally rise to above normal levels within 12 to 24 hours.  acetone bodies are reduce to normal concentrations usually witnin 24 hours.  th

General/multiple surgical laser system beam guide, single-use Australia - English - Department of Health (Therapeutic Goods Administration)

general/multiple surgical laser system beam guide, single-use

medisol pty ltd - 62600 - general/multiple surgical laser system beam guide, single-use - gmdn code: 62600 - general/multiple surgical laser system beam guide, single-use intended purpose: a sterile, flexible, probe-like device intended to be connected to a general/multiple surgical laser system to invasively direct and deliver laser energy for multiple different surgical applications (non-dedicated), which may include vaporization, ablation, coagulation, haemostasis, excision, resection, incision of soft and cartilaginous tissue, and/or fragmentation of urinary and biliary calculi. it typically consists of fibreoptic materials with an invasive laser-firing distal end. this is a single-use device.

Ophthalmic laser system beam guide Australia - English - Department of Health (Therapeutic Goods Administration)

ophthalmic laser system beam guide

device technologies australia pty ltd - 61162 - ophthalmic laser system beam guide - intended to delivery laser energy to the treatment area of the eye; some models to the retina during vitreoretinal surgery, others to the ciliary processes during glaucoma treatment.